Skip to content
10-Q

Quarterly Report

ProKidney Corp. PROK

0001193125-26-225841

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex Q1 2026 · Mar 31, 2026 $3.79M
Capex Q1 2026 · Mar 31, 2025 $1.14M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$41.68M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$29.59M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $101.9M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $108.54M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$1.02B
Stockholders Equity Q1 2026 · Dec 31, 2025 −$1.01B
Stockholders Equity Q1 2026 · Mar 31, 2025 −$998.55M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$994.95M
Current Liabilities Q1 2026 · Mar 31, 2026 $25.93M
Current Liabilities Q1 2026 · Dec 31, 2025 $30.74M
Total Liabilities Q1 2026 · Mar 31, 2026 $29.68M
Total Liabilities Q1 2026 · Dec 31, 2025 $34.78M
Current Assets Q1 2026 · Mar 31, 2026 $234.9M
Current Assets Q1 2026 · Dec 31, 2025 $280.68M
Total Assets Q1 2026 · Mar 31, 2026 $292.78M
Total Assets Q1 2026 · Dec 31, 2025 $335.57M
Sga Expense Q1 2026 · Mar 31, 2026 $11.32M
Sga Expense Q1 2026 · Mar 31, 2025 $14.36M
Rd Expense Q1 2026 · Mar 31, 2026 $33.84M
Rd Expense Q1 2026 · Mar 31, 2025 $27.26M
Net Income Q1 2026 · Mar 31, 2026 −$20.04M
Net Income Q1 2026 · Mar 31, 2025 −$16.73M
Operating Income Q1 2026 · Mar 31, 2026 −$44.93M
Operating Income Q1 2026 · Mar 31, 2025 −$41.39M
Revenue Q1 2026 · Mar 31, 2026 $226K
Revenue Q1 2026 · Mar 31, 2025 $230K